FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128449281> ?p ?o ?g. }

• W3128449281 abstract "<em>Demodex</em> infection gradually develops to <em>Demodex</em> blepharitis, which is characterized as chronic inflammation of the eyelid and meibomian gland (MG) and ultimately leads to MG dysfunction. In the present prospective study, the anti‑demodectic effects of an okra eyelid patch in patients <em>Demodex</em> blepharitis were investigated. A total of 52 patients with <em>Demodex</em> blepharitis with ocular discomfort were recruited. Patients were randomized to receive either an okra eyelid patch treatment (treatment group, n=27) or tea tree oil (TTO) eye care patch treatment (control group, n=25) for three months. The <em>Demodex</em> count, the ocular surface disease index (OSDI) score, MG expressibility (MGE) and meibum quality, Schirmer I test (SIT), tear break‑up time (TBUT) and corneal fluorescein staining (CFS) were determined prior to treatment and after 1 and 3 months of treatment. Changes in the parameters were compared between the treatment group and control group after 1 and 3 months of treatment. The average survival time in the okra group was 115.25±11.87 min, which was significantly lower compared with the average ST of 378.75±37.94 min in the blank group (P<0.01). After 3 months of okra eyelid patch treatment, the <em>Demodex</em> count was significantly reduced from 10.15±4.53 to 1.30±1.41 (P<0.01) and the OSDI score of the patients was reduced by 16.84±10.17 (P<0.01). There was no significant difference in the <em>Demodex</em> count (P=0.716) and OSDI (P=0.873) between the treatment and control groups. The rate of complete <em>Demodex</em> eradication in the treatment group (11/27, 40.74%) was slightly lower than that in the control group (12/25, 48%), but there was no significant difference between the two groups (χ²=0.277, P=0.598). Regarding the other ocular parameters, no significant difference was observed in the TBUT, meibum quality and MGE between the two groups (P<0.05). TTO group has a significantly improvement compared with Okra group in terms of SIT (P=0.035) and CFS (P=0.023). In conclusion, okra eyelid patch treatment is able to significantly eradicate ocular <em>Demodex</em> as well as markedly alleviate ocular symptoms. Due to causing less irritation than TTO, the okra eyelid patch may be more suitable for sensitive patients with <em>Demodex</em> blepharitis, such as the elderly and children. The study was registered as a clinical trial in the Chinese Clinical Trial Registry (ChiCTR) in November 2018 (registration no. ChiCTR‑1,800,019,466)." @default.
• W3128449281 created "2021-02-15" @default.
• W3128449281 creator A5014851777 @default.
• W3128449281 creator A5043332372 @default.
• W3128449281 date "2021-02-10" @default.
• W3128449281 modified "2023-09-26" @default.
• W3128449281 title "Anti‑demodectic effects of okra eyelid patch in <i>Demodex</i> blepharitis compared with tea tree oil" @default.
• W3128449281 cites W145780728 @default.
• W3128449281 cites W1970631135 @default.
• W3128449281 cites W1973899972 @default.
• W3128449281 cites W1979254055 @default.
• W3128449281 cites W1981351886 @default.
• W3128449281 cites W1985599642 @default.
• W3128449281 cites W1986630746 @default.
• W3128449281 cites W1990362820 @default.
• W3128449281 cites W1991575496 @default.
• W3128449281 cites W2001929218 @default.
• W3128449281 cites W2008321437 @default.
• W3128449281 cites W2028492221 @default.
• W3128449281 cites W2059776266 @default.
• W3128449281 cites W2069074740 @default.
• W3128449281 cites W2070032898 @default.
• W3128449281 cites W207501936 @default.
• W3128449281 cites W2078484734 @default.
• W3128449281 cites W2082421277 @default.
• W3128449281 cites W2091630088 @default.
• W3128449281 cites W2094034854 @default.
• W3128449281 cites W2108023270 @default.
• W3128449281 cites W2109727720 @default.
• W3128449281 cites W2110822694 @default.
• W3128449281 cites W2123859745 @default.
• W3128449281 cites W2140965757 @default.
• W3128449281 cites W2148491319 @default.
• W3128449281 cites W2166319653 @default.
• W3128449281 cites W2266238601 @default.
• W3128449281 cites W2555728493 @default.
• W3128449281 cites W2590860063 @default.
• W3128449281 cites W2621361010 @default.
• W3128449281 cites W2735203859 @default.
• W3128449281 cites W2737439597 @default.
• W3128449281 cites W2752039764 @default.
• W3128449281 cites W2806608783 @default.
• W3128449281 cites W2811069977 @default.
• W3128449281 cites W2896222793 @default.
• W3128449281 cites W2896767774 @default.
• W3128449281 cites W2906593454 @default.
• W3128449281 cites W2915001911 @default.
• W3128449281 cites W3046264918 @default.
• W3128449281 cites W78337089 @default.
• W3128449281 doi "https://doi.org/10.3892/etm.2021.9769" @default.
• W3128449281 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7903416" @default.
• W3128449281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33732311" @default.
• W3128449281 hasPublicationYear "2021" @default.
• W3128449281 type Work @default.
• W3128449281 sameAs 3128449281 @default.
• W3128449281 citedByCount "10" @default.
• W3128449281 countsByYear W31284492812021 @default.
• W3128449281 countsByYear W31284492812022 @default.
• W3128449281 countsByYear W31284492812023 @default.
• W3128449281 crossrefType "journal-article" @default.
• W3128449281 hasAuthorship W3128449281A5014851777 @default.
• W3128449281 hasAuthorship W3128449281A5043332372 @default.
• W3128449281 hasBestOaLocation W31284492811 @default.
• W3128449281 hasConcept C118487528 @default.
• W3128449281 hasConcept C16005928 @default.
• W3128449281 hasConcept C2777165675 @default.
• W3128449281 hasConcept C2779086053 @default.
• W3128449281 hasConcept C2779711295 @default.
• W3128449281 hasConcept C2780238520 @default.
• W3128449281 hasConcept C2781302119 @default.
• W3128449281 hasConcept C59822182 @default.
• W3128449281 hasConcept C71924100 @default.
• W3128449281 hasConcept C86803240 @default.
• W3128449281 hasConceptScore W3128449281C118487528 @default.
• W3128449281 hasConceptScore W3128449281C16005928 @default.
• W3128449281 hasConceptScore W3128449281C2777165675 @default.
• W3128449281 hasConceptScore W3128449281C2779086053 @default.
• W3128449281 hasConceptScore W3128449281C2779711295 @default.
• W3128449281 hasConceptScore W3128449281C2780238520 @default.
• W3128449281 hasConceptScore W3128449281C2781302119 @default.
• W3128449281 hasConceptScore W3128449281C59822182 @default.
• W3128449281 hasConceptScore W3128449281C71924100 @default.
• W3128449281 hasConceptScore W3128449281C86803240 @default.
• W3128449281 hasIssue "4" @default.
• W3128449281 hasLocation W31284492811 @default.
• W3128449281 hasLocation W31284492812 @default.
• W3128449281 hasOpenAccess W3128449281 @default.
• W3128449281 hasPrimaryLocation W31284492811 @default.
• W3128449281 hasRelatedWork W1769778261 @default.
• W3128449281 hasRelatedWork W2582847950 @default.
• W3128449281 hasRelatedWork W2740234602 @default.
• W3128449281 hasRelatedWork W3048703294 @default.
• W3128449281 hasRelatedWork W3128449281 @default.
• W3128449281 hasRelatedWork W3215730066 @default.
• W3128449281 hasRelatedWork W4307273424 @default.
• W3128449281 hasRelatedWork W4308695886 @default.
• W3128449281 hasRelatedWork W4321374966 @default.
• W3128449281 hasRelatedWork W4379376271 @default.
• W3128449281 hasVolume "21" @default.
• W3128449281 isParatext "false" @default.

• next